Serum LRG May Be Useful Biomarker Of Endoscopic Activity In Patients With IBD Who Are Taking Adalimumab, Researchers Say

May 05, 2021

Healio (5/4, Stonehill) reports, “Serum Leucine-rich alpha-2 glycoprotein [LRG] was a useful biomarker of endoscopic activity in patients with Crohn’s disease and ulcerative colitis taking Humira [adalimumab],” investigators concluded in a study that incl...